Ad is loading...
BEAM
Price
$23.58
Change
-$0.91 (-3.72%)
Updated
Nov 21 closing price
102 days until earnings call
KYMR
Price
$43.51
Change
-$0.54 (-1.23%)
Updated
Nov 21 closing price
90 days until earnings call
Ad is loading...

BEAM vs KYMR

Header iconBEAM vs KYMR Comparison
Open Charts BEAM vs KYMRBanner chart's image
Beam Therapeutics
Price$23.58
Change-$0.91 (-3.72%)
Volume$1.01M
CapitalizationN/A
Kymera Therapeutics
Price$43.51
Change-$0.54 (-1.23%)
Volume$510.85K
CapitalizationN/A
BEAM vs KYMR Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BEAM vs. KYMR commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Sell and KYMR is a StrongBuy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (BEAM: $23.58 vs. KYMR: $43.51)
Brand notoriety: BEAM and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 94% vs. KYMR: 118%
Market capitalization -- BEAM: $2.03B vs. KYMR: $2.85B
BEAM [@Biotechnology] is valued at $2.03B. KYMR’s [@Biotechnology] market capitalization is $2.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while KYMR’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 6 bearish.
  • KYMR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -10.38% price change this week, while KYMR (@Biotechnology) price change was -5.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

KYMR is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.85B) has a higher market cap than BEAM($2.03B). KYMR YTD gains are higher at: 70.896 vs. BEAM (-13.373). BEAM (-160.83M) and KYMR (-160.96M) have comparable annual earnings (EBITDA) . BEAM has more cash in the bank: 926M vs. KYMR (550M). KYMR has less debt than BEAM: KYMR (88.2M) vs BEAM (162M). BEAM has higher revenues than KYMR: BEAM (350M) vs KYMR (87.6M).
BEAMKYMRBEAM / KYMR
Capitalization2.03B2.85B71%
EBITDA-160.83M-160.96M100%
Gain YTD-13.37370.896-19%
P/E RatioN/AN/A-
Revenue350M87.6M400%
Total Cash926M550M168%
Total Debt162M88.2M184%
TECHNICAL ANALYSIS
Technical Analysis
BEAMKYMR
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
77%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLNMX23.870.25
+1.06%
MFS Global New Discovery R4
CVTRX51.060.22
+0.43%
Calamos Growth & Income A
HGHVX47.230.20
+0.43%
Hartford Healthcare R6
FPUKX25.450.09
+0.35%
Fidelity Puritan K
FEQZX13.29N/A
N/A
Fidelity Advisor Hedged Equity Fund Z

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with VERV. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then VERV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-1.23%
VERV - KYMR
50%
Loosely correlated
+1.10%
RXRX - KYMR
48%
Loosely correlated
-4.80%
RVMD - KYMR
46%
Loosely correlated
-0.51%
PRTA - KYMR
46%
Loosely correlated
+0.28%
BEAM - KYMR
46%
Loosely correlated
-3.72%
More